Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

  Breast Cancer

  Free Subscription


Articles published in Cancer Res

Retrieve available abstracts of 88 articles:
HTML format
Text format



Single Articles


    February 2012
  1. NAGAHASHI M , Ramachandran S, Kim EY, Allegood JC, et al
    Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis.
    Cancer Res. 2012;72:726-35.
    PubMed     Text format     Related articles    Abstract available



    January 2012
  2. BARONE I , Catalano S, Gelsomino L, Marsico S, et al
    Leptin mediates tumor-stromal interactions that promote the invasive growth of breast cancer cells.
    Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available



  3. VARGHESE JS , Thompson DJ, Michailidou K, Lindstrom S, et al
    Mammographic breast density and breast cancer: evidence of a shared genetic basis.
    Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available



  4. WITHANA NP , Blum G, Sameni M, Slaney C, et al
    Cathepsin B inhibition limits bone metastasis in breast cancer.
    Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available



  5. SHU XO , Long J, Lu W, Li C, et al
    Novel Genetic Markers of Breast Cancer Survival Identified by a Genome-Wide Association Study.
    Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available



  6. FITZGERALD DP , Subramanian P, Deshpande M, Graves C, et al
    Opposing Effects of Pigment Epithelium-Derived Factor on Breast Cancer Cell versus Neuronal Survival: Implication for Brain Metastasis and Metastasis-Induced Brain Damage.
    Cancer Res. 2012;72:144-153.
    PubMed     Text format     Related articles    Abstract available



    December 2011
  7. YU KD , Huang AJ, Fan L, Li WF, et al
    Genetic variants in oxidative stress-related genes predict chemoresistance in primary breast cancer: a prospective observational study and validation.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  8. ELIASSEN AH , Spiegelman D, Xu X, Keefer LK, et al
    Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



    November 2011
  9. CELLURALE C , Girnius N, Jiang F, Cavanagh-Kyros J, et al
    Role of JNK in mammary gland development and breast cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  10. OKUDA H , Kobayashi A, Xia B, Watabe M, et al
    Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem-like cells with macrophages and stromal cells.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  11. MCCARTAN D , Bolger J, Fagan A, Byrne C, et al
    Global characterization of the SRC-1 transcriptome identifies ADAM22 as an ER-independent mediator of endocrine resistant breast cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  12. HOU X , Huang F, Macedo LF, Harrington SC, et al
    Dual IGF-1R/InsR inhibitor BMS-754807 synergizes with hormonal agents in treatment of estrogen-dependent breast cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  13. MAMESSIER E , Sylvain A, Bertucci F, Castellano R, et al
    Human breast tumor cells induce self-tolerance mechanisms to avoid NKG2D-mediated and DNAM-mediated NK cell recognition.
    Cancer Res. 2011;71:6621-32.
    PubMed     Text format     Related articles    Abstract available



  14. SU JL , Cheng X, Yamaguchi H, Chang YW, et al
    FOXO3a-Dependent Mechanism of E1A-Induced Chemosensitization.
    Cancer Res. 2011;71:6878-87.
    PubMed     Text format     Related articles    Abstract available



    October 2011
  15. PAIS A , Gunanathan C, Margalit R, Biton IE, et al
    In vivo magnetic resonance imaging of the estrogen receptor in an orthotopic model of human breast cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  16. HA NH , Nair VS, Reddy SD, Mudvari P, et al
    Lactoferrin-Endothelin-1 Axis Contributes to the Development and Invasiveness of Triple Negative Breast Cancer Phenotypes.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



    September 2011
  17. LI Q , Shi L, Gui B, Yu W, et al
    Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  18. SIGNORI C , El-Bayoumy K, Russo J, Thompson HJ, et al
    Chemoprevention of Breast Cancer by Fish Oil in Preclinical Models: Trials and Tribulations.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  19. ELANGOVAN S , Ramachandran S, Venkatesan N, Ananth S, et al
    SIRT1 is essential for oncogenic signaling by estrogen/estrogen receptor {alpha} in breast cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  20. FOX EM , Miller TW, Balko JM, Kuba MG, et al
    A kinome-wide screen identifies the Insulin/IGF-1 receptor pathway as a mechanism of escape from hormone dependence in breast cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  21. DANG TT , Prechtl AM, Pearson GW
    Breast cancer subtype specific interactions with the microenvironment dictate mechanisms of invasion.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  22. JAVELAUD D , Alexaki VI, Dennler S, Mohammad KS, et al
    TGF-beta/SMAD/GLI2 signaling axis in cancer progression and metastasis.
    Cancer Res. 2011;71:5606-10.
    PubMed     Text format     Related articles    Abstract available



    August 2011
  23. MILLER LD , Coffman LG, Chou JW, Black MA, et al
    An Iron Regulatory Gene Signature Predicts Outcome in Breast Cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  24. QIAN PX , Zuo Z, Wu ZS, Meng X, et al
    Pivotal role of reduced let-7g expression in breast cancer invasion and metastasis.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  25. PAN D , Kocherginsky M, Conzen SD
    Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  26. ROSENTHAL DT , Iyer H, Escudero S, Bao L, et al
    p38{gamma} promotes breast cancer cell motility and metastasis through regulation of RhoC GTPase, cytoskeletal architecture, and a novel leading edge behavior.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  27. PRENZEL T , Begus-Nahrmann Y, Kramer F, Hennion M, et al
    Estrogen-Dependent Gene Transcription in Human Breast Cancer Cells Relies upon Proteasome-Dependent Monoubiquitination of Histone H2B.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  28. HU R , Peng G, Dai H, Breuer EK, et al
    ZNF668 functions as a tumor suppressor by regulating p53 stability and function in breast cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available




  29. Correction: Interaction between FGFR-2, STAT5, and Progesterone Receptors in Breast Cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles   




  30. Correction: TGF{beta}/TNF{alpha}-Mediated Epithelial-Mesenchymal Transition Generates Breast Cancer Stem Cells with a Claudin-Low Phenotype.
    Cancer Res. 2011.
    PubMed     Text format     Related articles   



  31. MARTINET L , Garrido I, Filleron T, Le Guellec S, et al
    Human Solid Tumors Contain High Endothelial Venules: Association with T- and B-Lymphocyte Infiltration and Favorable Prognosis in Breast Cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  32. STEVENS KN , Vachon CM, Lee AM, Slager S, et al
    Common breast cancer susceptibility loci are associated with triple negative breast cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  33. FACKLER MJ , Umbricht C, Williams D, Argani P, et al
    GENOME-WIDE METHYLATION ANALYSIS IDENTIFIES GENES SPECIFIC TO BREAST CANCER HORMONE RECEPTOR STATUS AND RISK OF RECURRENCE.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



    July 2011
  34. REBBECK TR , Mitra N, Domchek SM, Wan F, et al
    Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1 Interacting Genes.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  35. LIAO D , Liu Z, Wrasidlo WJ, Luo Y, et al
    Targeted therapeutic remodeling of the tumor microenvironment improves a Her-2 DNA vaccine and prevents recurrence in a murine breast cancer model.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  36. ZHANG H , Meng F, Wu S, Kreike B, et al
    Engagement of I-Branching {beta}-1, 6-N-Acetylglucosaminyltransferase 2 in Breast Cancer Metastasis and TGF-{beta} Signaling.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  37. BUFFA FM , Camps C, Winchester L, Snell CE, et al
    microRNA associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  38. FRADET A , Sorel H, Bouazza L, Goehrig D, et al
    Dual function of ERR{alpha}in breast cancer and bone metastasis formation:implication of VEGF and osteoprotegerin.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



    June 2011
  39. ZINDY P , Berge Y, Allal B, Filleron T, et al
    Formation of the eIF4F translation-initiation complex determines sensitivity to anticancer drugs targeting the EGFR and HER2 receptors.
    Cancer Res. 2011;71:4068-73.
    PubMed     Text format     Related articles    Abstract available



  40. PITTERI SJ , Kelly-Spratt KS, Gurley KE, Kennedy J, et al
    Tumor Microenvironment-Derived Proteins Dominate the Plasma Proteome Response During Breast Cancer Induction and Progression.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  41. O'TOOLE SA , Machalek DA, Shearer RF, Millar EK, et al
    Hedgehog Overexpression Is Associated with Stromal Interactions and Predicts for Poor Outcome in Breast Cancer.
    Cancer Res. 2011;71:4002-4014.
    PubMed     Text format     Related articles    Abstract available



    May 2011
  42. HIGGINBOTHAM KS , Breyer JP, Bradley KM, Schuyler PA, et al
    A Multistage Association Study Identifies a Breast Cancer Genetic Locus at NCOA7.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  43. ASIEDU MK , Ingle JN, Behrens MD, Radisky DC, et al
    TGF{beta}/TNF{alpha}-Mediated Epithelial-Mesenchymal Transition Generates Breast Cancer Stem Cells with a Claudin-Low Phenotype.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  44. CALVO V , Beato M
    BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters.
    Cancer Res. 2011;71:3422-31.
    PubMed     Text format     Related articles    Abstract available



  45. PADLER-KARAVANI V , Hurtado-Ziola N, Pu M, Yu H, et al
    Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer.
    Cancer Res. 2011;71:3352-63.
    PubMed     Text format     Related articles    Abstract available



    April 2011
  46. LAURENT J , Faes-Van't Hull E, Touvrey C, Kuonen F, et al
    Proangiogenic factor PlGF programs CD11b+ myelomonocytes in breast cancer during differentiation of their hematopoietic progenitors.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  47. ZHAO Y , Liu H, Liu Z, Ding Y, et al
    Overcoming Trastuzumab Resistance in Breast Cancer by Targeting Dysregulated Glucose Metabolism.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  48. HONG J , Zhou J, Fu J, He T, et al
    Phosphorylation of Serine 68 of Twist1 by MAPKs Stabilizes Twist1 Protein and Promotes Breast Cancer Cell Invasiveness.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  49. CERLIANI JP , Guillardoy T, Giulianelli S, Vaque JP, et al
    Interaction between FGFR-2, STAT5 and progesterone receptors in breast cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  50. DIRAT B , Bochet L, Dabek M, Daviaud D, et al
    Cancer-Associated Adipocytes Exhibit an Activated Phenotype and Contribute to Breast Cancer Invasion.
    Cancer Res. 2011;71:2455-2465.
    PubMed     Text format     Related articles    Abstract available



  51. JOSSON S , Nomura T, Lin JT, Huang WC, et al
    beta2-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells.
    Cancer Res. 2011;71:2600-10.
    PubMed     Text format     Related articles    Abstract available



    March 2011
  52. ZHANG Y , Yan LX, Wu QN, Du ZM, et al
    miR-125b is Methylated and Functions as A Tumor Suppressor by Regulating the ETS1 proto-oncogene in Human Invasive Breast Cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  53. OLKHANUD PB , Damdinsuren B, Bodogai M, Gress RE, et al
    Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4+ T cells to T regulatory cells.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  54. CAI Z , Sanchez A, Shi Z, Zhang T, et al
    Activation of Toll-like Receptor 5 on Breast Cancer Cells by Flagellin Suppresses Cell Proliferation and Tumor Growth.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  55. SRIDHARAN S , Basu A
    S6 Kinase 2 Promotes Breast Cancer Cell Survival via Akt.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  56. HILVO M , Denkert C, Lehtinen L, Muller B, et al
    Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  57. GONZALEZ ME , Duprie ML, Krueger H, Merajver SD, et al
    Histone Methyltransferase EZH2 Induces Akt-Dependent Genomic Instability and BRCA1 Inhibition in Breast Cancer.
    Cancer Res. 2011;71:2360-70.
    PubMed     Text format     Related articles    Abstract available



  58. AHMAD A , Aboukameel A, Kong D, Wang Z, et al
    Phosphoglucose Isomerase/Autocrine Motility Factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  59. SHI W , Gerster K, Alajez NM, Tsang J, et al
    MicroRNA-301 Mediates Proliferation and Invasion in Human Breast Cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  60. AKLI S , Van Pelt CS, Bui T, Meijer L, et al
    Cdk2 is required for breast cancer mediated by the low molecular weight isoform of cyclin E.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  61. BUCKLEY NE , Conlon SJ, Jirstrom K, Kay EW, et al
    The {Delta}Np63 Proteins Are Key Allies of BRCA1 in the Prevention of Basal-Like Breast Cancer.
    Cancer Res. 2011;71:1933-44.
    PubMed     Text format     Related articles    Abstract available



  62. HILL VK , Ricketts C, Bieche I, Vacher S, et al
    Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  63. GHOSH R , Narasanna A, Wang SE, Liu S, et al
    Trastuzumab has preferential activity against breast cancers driven by HER2 homodimers.
    Cancer Res. 2011;71:1871-82.
    PubMed     Text format     Related articles    Abstract available



    February 2011
  64. LAI D , Ho KC, Hao Y, Yang X, et al
    Taxol resistance in breast cancer cells is mediated by the Hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  65. LIM PK , Bliss SA, Patel SA, Taborga M, et al
    Gap Junction-Mediated Import of MicroRNA from Bone Marrow Stromal Cells Can Elicit Cell Cycle Quiescence in Breast Cancer Cells.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  66. QIN L , Chen X, Wu Y, Feng Z, et al
    Steroid Receptor Coactivator-1 Upregulates Integrin α5 Expression to Promote Breast Cancer Cell Adhesion and Migration.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  67. ARRIBAS J , Baselga J, Pedersen K, Parra-Palau JL, et al
    p95HER2 and Breast Cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  68. SALAUN B , Zitvogel L, Asselin-Paturel C, Morel Y, et al
    TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  69. WU J , Dauchy RT, Tirrell PC, Wu SS, et al
    Light at night activates IGF-1R/PDK1 signaling and accelerates tumor growth in human breast cancer xenografts.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  70. CAI Q , Wen W, Qu S, Li G, et al
    Replication and Functional Genomic Analyses of the Breast Cancer Susceptibility Locus at 6q25.1 Generalize Its Importance in Women of Chinese, Japanese, and European Ancestry.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  71. INOUE S , Ding H, Portilla-Arias J, Hu J, et al
    Polymalic Acid-Based Nanobiopolymer Provides Efficient Systemic Breast Cancer Treatment by Inhibiting both HER2/neu Receptor Synthesis and Activity.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  72. ZHANG H , Meng F, Liu G, Zhang B, et al
    Forkhead Transcription Factor Foxq1 Promotes Epithelial-Mesenchymal Transition and Breast Cancer Metastasis.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  73. CASADEI S , Norquist BM, Walsh T, Stray SM, et al
    Contribution to Familial Breast Cancer of Inherited Mutations in the BRCA2-interacting Protein PALB2.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



    January 2011
  74. AL-DHAHERI M , Wu J, Skliris GP, Li J, et al
    CARM1 is an important determinant of ER{alpha}-dependent breast cancer cell differentiation and proliferation in breast cancer cells.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  75. ZHANG L , Sullivan PS, Goodman JC, Gunaratne PH, et al
    MicroRNA-1258 Suppresses Breast Cancer Brain Metastasis by Targeting Heparanase.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  76. KHURANA A , Liu P, Mellone P, Lorenzon L, et al
    HSulf-1 Modulates FGF-2 and Hypoxia Mediated Migration and Invasion of Breast Cancer Cells.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  77. MADER CC , Oser M, Magalhaes MA, Bravo-Cordero J, et al
    An EGFR-Src-Arg-cortactin pathway mediates functional maturation of invadopodia and breast cancer cell invasion.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  78. BANERJEE S , Lin CF, Skinner KA, Schiffhauer LM, et al
    Heat Shock Protein 27 Differentiates Tolerogenic Macrophages That May Support Human Breast Cancer Progression.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  79. LIU S , Ginestier C, Ou SJ, Clouthier SG, et al
    Breast Cancer Stem Cells Are Regulated by Mesenchymal Stem Cells through Cytokine Networks.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  80. ZUO T , Liu TM, Lan X, Weng YI, et al
    Epigenetic Silencing Mediated Through Activated PI3K/AKT Signaling in Breast Cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  81. DEMERS M , Ho-Tin-Noe B, Schatzberg D, Yang JJ, et al
    Increased efficacy of breast cancer chemotherapy in thrombocytopenic mice.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  82. CASAS E , Kim J, Bendesky A, Ohno-Machado L, et al
    Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis.
    Cancer Res. 2011;71:245-54.
    PubMed     Text format     Related articles    Abstract available



  83. PERSSON H , Kvist A, Rego N, Staaf J, et al
    Identification of new microRNAs in paired normal and tumor breast tissue suggests a dual role for the ERBB2/Her2 gene.
    Cancer Res. 2011;71:78-86.
    PubMed     Text format     Related articles    Abstract available



    December 2010
  84. SIDDIQUI-JAIN A , Drygin D, Streiner N, Chua P, et al
    CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy.
    Cancer Res. 2010;70:10288-98.
    PubMed     Text format     Related articles    Abstract available



  85. CHO HM , Rosenblatt JD, Tolba K, Shin SJ, et al
    Delivery of NKG2D ligand using an anti-HER2 antibody-NKG2D ligand fusion protein results in an enhanced innate and adaptive antitumor response.
    Cancer Res. 2010;70:10121-30.
    PubMed     Text format     Related articles    Abstract available



  86. MICALIZZI DS , Wang CA, Farabaugh SM, Schiemann WP, et al
    Homeoprotein Six1 increases TGF-beta type I receptor and converts TGF-beta signaling from suppressive to supportive for tumor growth.
    Cancer Res. 2010;70:10371-80.
    PubMed     Text format     Related articles    Abstract available



  87. ZHOU C , Cohen DW, Wang Y, Lee HC, et al
    Integrated optical coherence tomography and microscopy for ex vivo multiscale evaluation of human breast tissues.
    Cancer Res. 2010;70:10071-9.
    PubMed     Text format     Related articles    Abstract available



  88. DEBLOIS G , Chahrour G, Perry MC, Sylvain-Drolet G, et al
    Transcriptional control of the ERBB2 amplicon by ERRalpha and PGC-1beta promotes mammary gland tumorigenesis.
    Cancer Res. 2010;70:10277-87.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: